« Previous
Next »
Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 4
, Pages 269-276
, April 2011
Metabolic syndrome in children with Prader–Willi syndrome: The effect of obesity
References
- . Prader–Willi syndrome. Clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med. 2005;7:1–20
- . Population prevalence and estimated birth incidence and mortality rate for people with Prader–Willi syndrome in one UK Health Region. J Med Genet. 2001;38:792–798
- . Diagnostic criteria for Prader–Willi syndrome. In: Butler MG, Lee PDK, Whitman BY editor. Management of Prader–Willi syndrome. 3rd ed. New York: Springer; 2006;p. 49–57
- . Early diagnosis and multidisciplinary care reduce the hospitalization time and duration of tube feeding and prevent early obesity in PWS infants. Horm Res. 2008;69:45–52
- . Peculiar body composition in patients with Prader–Labhart–Willi. Am J Clin Nutr. 1997;65:1369–1374
- . Body composition and fatness patterns in Prader–Willi syndrome: comparison with simple obesity. Obesity. 2006;14(10):1685–1690
- . Mortality in Prader–Willi syndrome. Am J Ment Retard. 2006;111:193–198
- . Cardiovascular morbidity and mortality of the metabolic syndrome. Med Clin North Am. 2007;91:1169–1184
- . Metabolic profile and body composition in adults with Prader–Willi syndrome and severe obesity. J Clin Endocrinol Metab. 2002;87:3590–3597
- Visceral adipose tissue and metabolic complications of obesity are reduced in Prader–Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab. 2001;86:4330–4338
- The impact of growth hormone/insulin-like growth factor-1 and nocturnal breathing disorders on cardiovascular features of adult patients with Prader–Willi syndrome. J Clin Endocrinol Metab. 2005;90:5639–5646
- . Insulin resistance and obesity-related factors in Prader–Willi syndrome: comparison with obese subjects. Clin Genet. 2004;67:230–239
- . Cardiovascular risk factors improve during 3
years of growth hormone therapy in Prader–Willi syndrome. Eur J Pediatr. 2000;159:835–842 - Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362–2374
- Prader–Willi syndrome: consensus diagnostic criteria. Pediatrics. 1993;91:398–402
- CDC growth charts: United States. Adv Data. 2000;1–27
- . Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
- . The Fourth Report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–576
- . National Cholesterol Education Program. Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89:495–501
- . Distribution of lipoproteins by age and gender in adolescents. Circulation. 2006;114:1056–1062
- . Diagnosis and classification of Diabetes Mellitus. Diabetes Care. 2005;28:S37–S42
- . Exact logistic regression: theory and examples. Stat Med. 1995;14:2143–2160
- . Multivariable model-building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables. Chichester: Wiley; 2008;
- . Prader–Willi syndrome: the care and treatment of infants, children, and adults. Adv Pediatr. 2004;51:409–434
- . Prader–Willi syndrome: causes of death in an international series of 27 cases. Am J Med Genet Part A. 2004;124A:333–338
- . Clinical findings and natural history of Prader–Willi syndrome. In: Butler MG, Lee PDK, Whitman BY editor. Management of Prader–Willi syndrome. 3rd ed. New York: Springer; 2006;p. 3–48
- . Premature coronary artery atherosclerosis in a patient with Prader–Willi syndrome. Am J Med Genet. 1987;28:873–880
- . Death in adults with Prader–Willi syndrome may be correlated with maternal uniparental disomy. J Med Genet. 2003;40:e63
- Minimum prevalence, birth incidence and cause of death for Prader–Willi syndrome in Flanders. Eur J Med Genet. 2004;12:238–240
- . Characteristics of cardiac and vascular structure and function in Prader–Willi syndrome. Clin Endocrinol. 2007;66:771–777
- . The metabolic syndrome. Arch Intern Med. 2003;163:427–436
- . Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr. 2000;159:91–94
- . Metabolic syndrome among children and adolescents aged 10–18
years. Diabetes Care. 2004;27(10):2516–2517 - . Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes. 2004;28:833–841
- . Gastrointestinal system, obesity, and body composition. In: Butler MG, Lee PDK, Whitman BY editor. Management of Prader–Willi syndrome. 3rd ed. New York: Springer; 2006;p. 153–200
- . Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–194
- . Characterization of alterations in carbohydrate metabolism in children with Prader–Willi syndrome. J Pediatr Endocrinol Metab. 2006;19:911–918
- . Low insulin, IGF-I and IGFBP-3 levels in children with Prader–Labhart–Willi syndrome. Eur J Pediatr. 1998;157:890–893
- . Prevalence of metabolic syndrome in American adolescents. Circulation. 2004;110:2494–2497
- . Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999–2002. J Pediatr. 2008;152:165–170
PII: S0939-4753(09)00238-5
doi: 10.1016/j.numecd.2009.10.004
© 2009 Elsevier B.V. All rights reserved.
« Previous
Next »
Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 4
, Pages 269-276
, April 2011
